Π.Ο.Υ. - Περιφέρεια Αμερικής (ηπείρ& | World Obesity Federation Global Obesity Observatory

Επισκόπηση
Επιπολασμός της παχυσαρκίας
Παράγοντες
Συννοσηρότητες

Φόρτωση δεδομένων, περιμένετε

Επιπολασμός της παχυσαρκίας

Report cards

Our report cards collate all the most-recent graphics for this region. If you would like to produce a custom report based on selected graphics, just tap the Add to custom PDF button below the graphics you would like to use.

Λήψη κάρτας αναφοράς

Report card (adult data)

Report card (child data)

Report card (under-5s data)

Παράγοντες

Ανεπαρκής δραστηριότητα

Κατανάλωση αναψυκτικών

Κατανάλωση φρούτων

Κατανάλωση λαχανικών

Κατανάλωση γρήγορου φαγητού

Κατανάλωση επεξεργασμένου κρέατος

Κατανάλωση δημητριακών

Ψυχική υγεία

Λήψη κάρτας αναφοράς

Συννοσηρότητες

Καρκίνος του οισοφάγου

Καρκίνος του μαστού

Κολοορθικός καρκίνος

Καρκίνος του παγκρέατος

Καρκίνος της χοληδόχου κύστης

Καρκίνος του νεφρού

Καρκίνος της μήτρας

Αυξημένη αρτηριακή πίεση

Αυξημένη χοληστερόλη

Αυξημένη γλυκόζη αίματος νηστε

Επιπολασμός του διαβήτη

Λήψη κάρτας αναφοράς

Επιπολασμός της παχυσαρκίας

Ενήλικες

Τύπος έρευνας:	Countries marked with a * are using self-reported data.
Σημειώσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.
Εκτός εάν υποδεικνύεται διαφορετικά, το υπερβ&omi.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Ανδρες

Τύπος έρευνας:	Countries marked with a * are using self-reported data.
Σημειώσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.
Εκτός εάν υποδεικνύεται διαφορετικά, το υπερβ&omi.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Γυναίκες

Τύπος έρευνας:	Countries marked with a * are using self-reported data.
Σημειώσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.
Εκτός εάν υποδεικνύεται διαφορετικά, το υπερβ&omi.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Αγόρια

Τύπος έρευνας:	Countries marked with a * are using self-reported data.
Σημειώσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Κορίτσια

Τύπος έρευνας:	Countries marked with a * are using self-reported data.
Σημειώσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Παιδιά

Τύπος έρευνας:	Countries marked with a * are using self-reported data.
Σημειώσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

0-5 years

Σημειώσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

0-5 years boys

Σημειώσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

0-5 years girls

Σημειώσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Î•Ï€Î¹Ï€Î¿Î»Î±ÏƒÎ¼ÏŒÏ‚ Ï„Î·Ï‚ Ï€Î±Ï‡Ï…ÏƒÎ±ÏÎºÎ¯Î±Ï‚ (measured data only)

Î•Î½Î®Î»Î¹ÎºÎµÏ‚

ΣημειÏŽσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.
Î•ÎºÏ„ÏŒÏ‚ ÎµÎ¬Î½ Ï…Ï€Î¿Î´ÎµÎ¹ÎºÎ½ÏÎµÏ„Î±Î¹ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬, Ï„Î¿ Ï…Ï€ÎµÏÎ²&omi.

Î‘Î½Î´ÏÎµÏ‚

ΣημειÏŽσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.
Î•ÎºÏ„ÏŒÏ‚ ÎµÎ¬Î½ Ï…Ï€Î¿Î´ÎµÎ¹ÎºÎ½ÏÎµÏ„Î±Î¹ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬, Ï„Î¿ Ï…Ï€ÎµÏÎ²&omi.

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚

ΣημειÏŽσεις:	Different methodologies have been used to collect this data and so it is not strictly comparable.
Î•ÎºÏ„ÏŒÏ‚ ÎµÎ¬Î½ Ï…Ï€Î¿Î´ÎµÎ¹ÎºÎ½ÏÎµÏ„Î±Î¹ Î´Î¹Î±Ï†Î¿ÏÎµÏ„Î¹ÎºÎ¬, Ï„Î¿ Ï…Ï€ÎµÏÎ²&omi.

Î‘Î³ÏŒÏÎ¹Î±

ΣημειÏŽσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±

ΣημειÏŽσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

Î Î±Î¹Î´Î¹Î¬

ΣημειÏŽσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

0-5 years

ΣημειÏŽσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

0-5 years boys

ΣημειÏŽσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

0-5 years girls

ΣημειÏŽσεις:

Different methodologies have been used to collect this data and so it is not strictly comparable.

Î‘Î½ÎµÏ€Î±ÏÎºÎ®Ï‚ Î´ÏÎ±ÏƒÏ„Î·ÏÎ¹ÏŒÏ„Î·Ï„Î±

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2022

Î¤ÏÏ€Î¿Ï‚ ÎÏÎµÏ…Î½Î±Ï‚:	Î‘Ï…Ï„Î¿Î±Î½Î±Ï†ÎµÏÏŒÎ¼ÎµÎ½Î¿Î¹
Î—Î»Î¹ÎºÎ¯Î±:	18+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-)
ΟρισμοÎ¯:	Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent.

Î‘Î½Î´ÏÎµÏ‚, 2022

Î¤ÏÏ€Î¿Ï‚ ÎÏÎµÏ…Î½Î±Ï‚:	Î‘Ï…Ï„Î¿Î±Î½Î±Ï†ÎµÏÏŒÎ¼ÎµÎ½Î¿Î¹
Î—Î»Î¹ÎºÎ¯Î±:	18+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-)
ΟρισμοÎ¯:	Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent.

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î¤ÏÏ€Î¿Ï‚ ÎÏÎµÏ…Î½Î±Ï‚:	Î‘Ï…Ï„Î¿Î±Î½Î±Ï†ÎµÏÏŒÎ¼ÎµÎ½Î¿Î¹
Î—Î»Î¹ÎºÎ¯Î±:	18+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	WHO (2024). Prevalence of insufficient physical activity among adults aged 18-years age-standardized estimate in 2022. Available at https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-insufficient-physical-activity-among-adults-aged-18-years-(age-standardized-estimate)-(-)
ΟρισμοÎ¯:	Percent of population attaining less than 150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent.

Î‘Î³ÏŒÏÎ¹Î±, 2021-2022

Î¤ÏÏ€Î¿Ï‚ ÎÏÎµÏ…Î½Î±Ï‚:	Î‘Ï…Ï„Î¿Î±Î½Î±Ï†ÎµÏÏŒÎ¼ÎµÎ½Î¿Î¹
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Rakic JG, Hamrik Z, Dzielska A, Felder-Puig R, Oja L, Bakalár P et al. A focus on adolescent physical activity, eating behaviours, weight status and body image in Europe, central Asia and Canada. Health Behaviour in School-aged Children international report from the 2021/2022 survey. Volume 4. Copenhagen: WHO Regional Office for Europe; 2024. Licence: CC BY-NC-SA 3.0 IGO.Health Behaviour in School-aged Children study (2023), Data browser (findings from the 2021/22 international HBSC survey): https://data-browser.hbsc.org.
ΣημειÏŽσεις:	Young people were asked to report the number of days over the past week during which they were physically active for a total of at least 60 minutes. The question was introduced by text defining moderate-to-vigorous physical activity (MVPA) as any activity that increases the heart rate and makes the person get out of breath some of the time, with examples provided. Findings presented on the Observatory show the proportions who report less than 60 minutes of MVPA daily. NB. National except Belgium (Flemish speaking region only)
ΟρισμοÎ¯:	% reporting less than 60 minutes of MVPA daily

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±, 2021-2022

Î¤ÏÏ€Î¿Ï‚ ÎÏÎµÏ…Î½Î±Ï‚:	Î‘Ï…Ï„Î¿Î±Î½Î±Ï†ÎµÏÏŒÎ¼ÎµÎ½Î¿Î¹
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Rakic JG, Hamrik Z, Dzielska A, Felder-Puig R, Oja L, Bakalár P et al. A focus on adolescent physical activity, eating behaviours, weight status and body image in Europe, central Asia and Canada. Health Behaviour in School-aged Children international report from the 2021/2022 survey. Volume 4. Copenhagen: WHO Regional Office for Europe; 2024. Licence: CC BY-NC-SA 3.0 IGO.Health Behaviour in School-aged Children study (2023), Data browser (findings from the 2021/22 international HBSC survey): https://data-browser.hbsc.org.
ΣημειÏŽσεις:	Young people were asked to report the number of days over the past week during which they were physically active for a total of at least 60 minutes. The question was introduced by text defining moderate-to-vigorous physical activity (MVPA) as any activity that increases the heart rate and makes the person get out of breath some of the time, with examples provided. Findings presented on the Observatory show the proportions who report less than 60 minutes of MVPA daily. NB. National except Belgium (Flemish speaking region only)
ΟρισμοÎ¯:	% reporting less than 60 minutes of MVPA daily

Prevalence of at least daily soft drink consumption

Αγόρια, 2021-2022

Τύπος έρευνας:	Αυτοαναφερόμενοι
Γεωγραφική κάλυψη:	Εθνική
Παραπομπές:	Health Behaviour in School-aged Children study (2023), Data browser (findings from the 2021/22 international HBSC survey): https://data-browser.hbsc.org
Ορισμοί:	Proportion who reported drinking sugary soft drinks daily (at least once)

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Κορίτσια, 2021-2022

Τύπος έρευνας:	Αυτοαναφερόμενοι
Γεωγραφική κάλυψη:	Εθνική
Παραπομπές:	Health Behaviour in School-aged Children study (2023), Data browser (findings from the 2021/22 international HBSC survey): https://data-browser.hbsc.org
Ορισμοί:	Proportion who reported drinking sugary soft drinks daily (at least once)

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Μέση ημερήσια συχνότητα κατανάλωσης ανθρακούχων αναψυκτικών

Παιδιά, 2009-2015

Τύπος έρευνας:	Από μέτρηση
Ηλικία:	12-17
Παραπομπές:	Beal et al. (2019). Global Patterns of Adolescent Fruit, Vegetable, Carbonated Soft Drink, and Fast-food consumption: A meta-analysis of global school-based student health surveys. Food and Nutrition Bulletin. https://doi.org/10.1177/0379572119848287 sourced from Food Systems Dashboard http://www.foodsystemsdashboard.org/food-system

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2017

Î—Î»Î¹ÎºÎ¯Î±:	25+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
ΟρισμοÎ¯:	Estimated per capita fruit intake (g/day)

Prevalence of less-than-daily fruit consumption

Αγόρια, 2021-2022

Τύπος έρευνας:	Αυτοαναφερόμενοι
Γεωγραφική κάλυψη:	Εθνική
Παραπομπές:	Rakic JG, Hamrik Z, Dzielska A, Felder-Puig R, Oja L, Bakalár P et al. A focus on adolescent physical activity, eating behaviours, weight status and body image in Europe, central Asia and Canada. Health Behaviour in School-aged Children international report from the 2021/2022 survey. Volume 4. Copenhagen: WHO Regional Office for Europe; 2024. Licence: CC BY-NC-SA 3.0 IGO
Ορισμοί:	Proportion who reported eating fruit less than daily

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Κορίτσια, 2021-2022

Τύπος έρευνας:	Αυτοαναφερόμενοι
Γεωγραφική κάλυψη:	Εθνική
Παραπομπές:	Rakic JG, Hamrik Z, Dzielska A, Felder-Puig R, Oja L, Bakalár P et al. A focus on adolescent physical activity, eating behaviours, weight status and body image in Europe, central Asia and Canada. Health Behaviour in School-aged Children international report from the 2021/2022 survey. Volume 4. Copenhagen: WHO Regional Office for Europe; 2024. Licence: CC BY-NC-SA 3.0 IGO
Ορισμοί:	Proportion who reported eating fruit less than daily

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Prevalence of less-than-daily vegetable consumption

Αγόρια, 2021-2022

Τύπος έρευνας:	Αυτοαναφερόμενοι
Γεωγραφική κάλυψη:	Εθνική
Παραπομπές:	Rakic JG, Hamrik Z, Dzielska A, Felder-Puig R, Oja L, Bakalár P et al. A focus on adolescent physical activity, eating behaviours, weight status and body image in Europe, central Asia and Canada. Health Behaviour in School-aged Children international report from the 2021/2022 survey. Volume 4. Copenhagen: WHO Regional Office for Europe; 2024. Licence: CC BY-NC-SA 3.0 IGO
Ορισμοί:	Prevalence of less-than-daily vegetable consumption (% less-than-daily vegetable consumption)

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Κορίτσια, 2021-2022

Τύπος έρευνας:	Αυτοαναφερόμενοι
Γεωγραφική κάλυψη:	Εθνική
Παραπομπές:	Rakic JG, Hamrik Z, Dzielska A, Felder-Puig R, Oja L, Bakalár P et al. A focus on adolescent physical activity, eating behaviours, weight status and body image in Europe, central Asia and Canada. Health Behaviour in School-aged Children international report from the 2021/2022 survey. Volume 4. Copenhagen: WHO Regional Office for Europe; 2024. Licence: CC BY-NC-SA 3.0 IGO
Ορισμοί:	Prevalence of less-than-daily vegetable consumption (% less-than-daily vegetable consumption)

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Μέση εβδομαδιαία συχνότητα κατανάλωσης γρήγορου φαγητού

Παιδιά, 2009-2015

Ηλικία:	12-17
Παραπομπές:	Beal et al. (2019). Global Patterns of Adolescent Fruit, Vegetable, Carbonated Soft Drink, and Fast-food consumption: A meta-analysis of global school-based student health surveys. Food and Nutrition Bulletin. https://doi.org/10.1177/0379572119848287 sourced from Food Systems Dashboard http://www.foodsystemsdashboard.org/food-system

Λήψη γραφήματος Προσθήκη σε εξατομικευμένο pdf

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2017

Î—Î»Î¹ÎºÎ¯Î±:	25+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
ΟρισμοÎ¯:	Estimated per capita processed meat intake (g per day)

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2017

Î¤ÏÏ€Î¿Ï‚ ÎÏÎµÏ…Î½Î±Ï‚:	Î‘Ï€ÏŒ Î¼ÎÏ„ÏÎ·ÏƒÎ·
Î—Î»Î¹ÎºÎ¯Î±:	25+
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/
ΟρισμοÎ¯:	Estimated per-capita whole grains intake (g/day)

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2021

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
ΟρισμοÎ¯:	Number living with depression per 100,000 population (adults 20+ years)

Î‘Î½Î´ÏÎµÏ‚, 2021

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
ΟρισμοÎ¯:	Number living with depression per 100,000 population (adults 20+ years)

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2021

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
ΟρισμοÎ¯:	Number living with depression per 100,000 population (adults 20+ years)

Î Î±Î¹Î´Î¹Î¬, 2021

Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
ΟρισμοÎ¯:	Number living with depressive disorder per 100,000 population (Under 20 years of age)

Î‘Î³ÏŒÏÎ¹Î±, 2021

Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
ΟρισμοÎ¯:	Number living with depressive disorder per 100,000 population (Under 20 years of age)

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±, 2021

Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)
ΟρισμοÎ¯:	Number living with depressive disorder per 100,000 population (Under 20 years of age)

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2021

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
ΟρισμοÎ¯:	Number living with anxiety per 100,000 population

Î‘Î½Î´ÏÎµÏ‚, 2021

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
ΟρισμοÎ¯:	Number living with anxiety per 100,000 population

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2021

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25).
ΟρισμοÎ¯:	Number living with anxiety per 100,000 population

Î Î±Î¹Î´Î¹Î¬, 2021

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:

Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Global Burden of Disease (GBD) Study 2021. Seattle, WA: IHME, University of Washington, 2023. Available from http://vizhub.healthdata.org/gbd-compare. (Last accessed 23.04.25)

Î‘Î³ÏŒÏÎ¹Î±, 2021

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±, 2021

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î¿Ï… Î¿Î¹ÏƒÎ¿Ï†Î¬Î³Î¿Ï…

Î‘Î½Î´ÏÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Indicence per 100,000

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Indicence per 100,000

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î¿Ï… Î¼Î±ÏƒÏ„Î¿Ï

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Incidence per 100,000

ÎšÎ¿Î»Î¿Î¿ÏÎ¸Î¹ÎºÏŒÏ‚ ÎºÎ±ÏÎºÎ¯Î½Î¿Ï‚

Î‘Î½Î´ÏÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Incidence per 100,000

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Incidence per 100,000

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î¿Ï… Ï€Î±Î³ÎºÏÎÎ±Ï„Î¿Ï‚

Î‘Î½Î´ÏÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Incidence per 100,000

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Incidence per 100,000

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î·Ï‚ Ï‡Î¿Î»Î·Î´ÏŒÏ‡Î¿Ï… ÎºÏÏƒÏ„Î·Ï‚

Î‘Î½Î´ÏÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Indicence per 100,000

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Indicence per 100,000

ΚαρκÎ¯νος του νεφροÏ

Î‘Î½Î´ÏÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Incidence per 100,000

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î“ÎµÏ‰Î³ÏÎ±Ï†Î¹ÎºÎ® ÎºÎ¬Î»Ï…ÏˆÎ·:	ΕθνικÎ®
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Incidence per 100,000

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î·Ï‚ Î¼Î®Ï„ÏÎ±Ï‚

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î—Î»Î¹ÎºÎ¯Î±:	20+
Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today, accessed [16.07.24]
ΟρισμοÎ¯:	Incidence per 100,000

Î‘Ï…Î¾Î·Î¼ÎÎ½Î· Î±ÏÏ„Î·ÏÎ¹Î±ÎºÎ® Ï€Î¯ÎµÏƒÎ·

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2015

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A875?lang=en
ΟρισμοÎ¯:	Age Standardised estimated % Raised blood pressure 2015 (SBP>=140 OR DBP>=90).

Î‘Î½Î´ÏÎµÏ‚, 2015

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A875?lang=en
ΟρισμοÎ¯:	Age Standardised estimated % Raised blood pressure 2015 (SBP>=140 OR DBP>=90).

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2015

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A875?lang=en
ΟρισμοÎ¯:	Age Standardised estimated % Raised blood pressure 2015 (SBP>=140 OR DBP>=90).

ΑυξημÎνη χοληστερÏŒλη

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2008

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A885
ΟρισμοÎ¯:	% Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate).

Î‘Î½Î´ÏÎµÏ‚, 2008

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A885
ΟρισμοÎ¯:	% Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate).

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2008

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A885
ΟρισμοÎ¯:	% Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate).

ΑυξημÎνη γλυκÏŒζη αÎ¯ματος νηστε

Î‘Î½Î´ÏÎµÏ‚, 2014

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A869?lang=en
ΟρισμοÎ¯:	Age Standardised % raised fasting blood glucose (>= 7.0 mmol/L or on medication).

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2014

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:	Global Health Observatory data repository, World Health Organisation, http://apps.who.int/gho/data/node.main.A869?lang=en
ΟρισμοÎ¯:	Age Standardised % raised fasting blood glucose (>= 7.0 mmol/L or on medication).

Î•Ï€Î¹Ï€Î¿Î»Î±ÏƒÎ¼ÏŒÏ‚ Ï„Î¿Ï… Î´Î¹Î±Î²Î®Ï„Î·

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2024

Î Î±ÏÎ±Ï€Î¿Î¼Ï€ÎÏ‚:

Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 11th edn. Brussels, Belgium:International Diabetes Federation, 2025. http://www.diabetesatlas.org

Επιπολασμός της παχυσαρκίας

Report cards

Λήψη κάρτας αναφοράς

Report card (adult data)

Report card (child data)

Report card (under-5s data)

Παράγοντες

Ανεπαρκής δραστηριότητα

Κατανάλωση αναψυκτικών

Κατανάλωση φρούτων

Κατανάλωση λαχανικών

Κατανάλωση γρήγορου φαγητού

Κατανάλωση επεξεργασμένου κρέατος

Κατανάλωση δημητριακών

Ψυχική υγεία

Λήψη κάρτας αναφοράς

Συννοσηρότητες

Καρκίνος του οισοφάγου

Καρκίνος του μαστού

Κολοορθικός καρκίνος

Καρκίνος του παγκρέατος

Καρκίνος της χοληδόχου κύστης

Καρκίνος του νεφρού

Καρκίνος της μήτρας

Αυξημένη αρτηριακή πίεση

Αυξημένη χοληστερόλη

Αυξημένη γλυκόζη αίματος νηστε

Επιπολασμός του διαβήτη

Λήψη κάρτας αναφοράς

Επιπολασμός της παχυσαρκίας

Ενήλικες

Ανδρες

Γυναίκες

Αγόρια

Κορίτσια

Παιδιά

0-5 years

0-5 years boys

0-5 years girls

Î•Ï€Î¹Ï€Î¿Î»Î±ÏƒÎ¼ÏŒÏ‚ Ï„Î·Ï‚ Ï€Î±Ï‡Ï…ÏƒÎ±ÏÎºÎ¯Î±Ï‚ (measured data only)

Î•Î½Î®Î»Î¹ÎºÎµÏ‚

Î‘Î½Î´ÏÎµÏ‚

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚

Î‘Î³ÏŒÏÎ¹Î±

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±

Î Î±Î¹Î´Î¹Î¬

0-5 years

0-5 years boys

0-5 years girls

Î‘Î½ÎµÏ€Î±ÏÎºÎ®Ï‚ Î´ÏÎ±ÏƒÏ„Î·ÏÎ¹ÏŒÏ„Î·Ï„Î±

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2022

Î‘Î½Î´ÏÎµÏ‚, 2022

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2022

Î‘Î³ÏŒÏÎ¹Î±, 2021-2022

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±, 2021-2022

Prevalence of at least daily soft drink consumption

Αγόρια, 2021-2022

Κορίτσια, 2021-2022

Μέση ημερήσια συχνότητα κατανάλωσης ανθρακούχων αναψυκτικών

Παιδιά, 2009-2015

Î•ÎºÏ„Î¹Î¼ÏŽÎ¼ÎµÎ½Î· ÎºÎ±Ï„Î¬ ÎºÎµÏ†Î±Î»Î®Î½ Ï€ÏÏŒÏƒÎ»Î·ÏˆÎ· Ï†ÏÎ¿ÏÏ„Ï‰Î½

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2017

Prevalence of less-than-daily fruit consumption

Αγόρια, 2021-2022

Κορίτσια, 2021-2022

Prevalence of less-than-daily vegetable consumption

Αγόρια, 2021-2022

Κορίτσια, 2021-2022

Μέση εβδομαδιαία συχνότητα κατανάλωσης γρήγορου φαγητού

Παιδιά, 2009-2015

Î•ÎºÏ„Î¹Î¼ÏŽÎ¼ÎµÎ½Î· ÎºÎ±Ï„Î¬ ÎºÎµÏ†Î±Î»Î®Î½ Ï€ÏÏŒÏƒÎ»Î·ÏˆÎ· ÎµÏ€ÎµÎ¾ÎµÏÎ³Î±ÏƒÎ¼Î­Î½Î¿Ï… &k

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2017

Î•ÎºÏ„Î¹Î¼ÏŽÎ¼ÎµÎ½Î· ÎºÎ±Ï„Î¬ ÎºÎµÏ†Î±Î»Î®Î½ Ï€ÏÏŒÏƒÎ»Î·ÏˆÎ· Î´Î·Î¼Î·Ï„ÏÎ¹Î±ÎºÏŽÎ½ Î¿Î»Î¹ÎºÎ®&s

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2017

Î¨Ï…Ï‡Î¹ÎºÎ® Ï…Î³ÎµÎ¯Î± - ÎºÎ±Ï„Î±Î¸Î»Î¹Ï€Ï„Î¹ÎºÎ­Ï‚ Î´Î¹Î±Ï„Î±ÏÎ±Ï‡Î­Ï‚

Î•Î½Î®Î»Î¹ÎºÎµÏ‚, 2021

Î‘Î½Î´ÏÎµÏ‚, 2021

Î“Ï…Î½Î±Î¯ÎºÎµÏ‚, 2021

Î Î±Î¹Î´Î¹Î¬, 2021

Î‘Î³ÏŒÏÎ¹Î±, 2021

Î•Ï€Î¹Ï€Î¿Î»Î±ÏƒÎ¼ÏŒÏ‚ Ï„Î·Ï‚ Ï€Î±Ï‡Ï…ÏƒÎ±ÏÎºÎ¯Î±Ï‚ (measured data only)

Î‘Î½Î´ÏÎµÏ‚

Î‘Î³ÏŒÏÎ¹Î±

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±

Î‘Î½ÎµÏ€Î±ÏÎºÎ®Ï‚ Î´ÏÎ±ÏƒÏ„Î·ÏÎ¹ÏŒÏ„Î·Ï„Î±

Î‘Î½Î´ÏÎµÏ‚, 2022

Î‘Î³ÏŒÏÎ¹Î±, 2021-2022

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±, 2021-2022

Î•ÎºÏ„Î¹Î¼ÏŽÎ¼ÎµÎ½Î· ÎºÎ±Ï„Î¬ ÎºÎµÏ†Î±Î»Î®Î½ Ï€ÏÏŒÏƒÎ»Î·ÏˆÎ· Ï†ÏÎ¿ÏÏ„Ï‰Î½

Î•ÎºÏ„Î¹Î¼ÏŽÎ¼ÎµÎ½Î· ÎºÎ±Ï„Î¬ ÎºÎµÏ†Î±Î»Î®Î½ Ï€ÏÏŒÏƒÎ»Î·ÏˆÎ· ÎµÏ€ÎµÎ¾ÎµÏÎ³Î±ÏƒÎ¼ÎÎ½Î¿Ï… &k

Î•ÎºÏ„Î¹Î¼ÏŽÎ¼ÎµÎ½Î· ÎºÎ±Ï„Î¬ ÎºÎµÏ†Î±Î»Î®Î½ Ï€ÏÏŒÏƒÎ»Î·ÏˆÎ· Î´Î·Î¼Î·Ï„ÏÎ¹Î±ÎºÏŽÎ½ Î¿Î»Î¹ÎºÎ®&s

Î¨Ï…Ï‡Î¹ÎºÎ® Ï…Î³ÎµÎ¯Î± - ÎºÎ±Ï„Î±Î¸Î»Î¹Ï€Ï„Î¹ÎºÎÏ‚ Î´Î¹Î±Ï„Î±ÏÎ±Ï‡ÎÏ‚

Î‘Î½Î´ÏÎµÏ‚, 2021

Î‘Î³ÏŒÏÎ¹Î±, 2021

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±, 2021

Î¨Ï…Ï‡Î¹ÎºÎ® Ï…Î³ÎµÎ¯Î± - Î±Î³Ï‡ÏŽÎ´ÎµÎ¹Ï‚ Î´Î¹Î±Ï„Î±ÏÎ±Ï‡ÎÏ‚

Î‘Î½Î´ÏÎµÏ‚, 2021

Î‘Î³ÏŒÏÎ¹Î±, 2021

ÎšÎ¿ÏÎ¯Ï„ÏƒÎ¹Î±, 2021

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î¿Ï… Î¿Î¹ÏƒÎ¿Ï†Î¬Î³Î¿Ï…

Î‘Î½Î´ÏÎµÏ‚, 2022

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î¿Ï… Î¼Î±ÏƒÏ„Î¿Ï

ÎšÎ¿Î»Î¿Î¿ÏÎ¸Î¹ÎºÏŒÏ‚ ÎºÎ±ÏÎºÎ¯Î½Î¿Ï‚

Î‘Î½Î´ÏÎµÏ‚, 2022

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î¿Ï… Ï€Î±Î³ÎºÏÎÎ±Ï„Î¿Ï‚

Î‘Î½Î´ÏÎµÏ‚, 2022

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î·Ï‚ Ï‡Î¿Î»Î·Î´ÏŒÏ‡Î¿Ï… ÎºÏÏƒÏ„Î·Ï‚

Î‘Î½Î´ÏÎµÏ‚, 2022

ΚαρκÎ¯νος του νεφροÏ

Î‘Î½Î´ÏÎµÏ‚, 2022

ÎšÎ±ÏÎºÎ¯Î½Î¿Ï‚ Ï„Î·Ï‚ Î¼Î®Ï„ÏÎ±Ï‚

Î‘Ï…Î¾Î·Î¼ÎÎ½Î· Î±ÏÏ„Î·ÏÎ¹Î±ÎºÎ® Ï€Î¯ÎµÏƒÎ·

Î‘Î½Î´ÏÎµÏ‚, 2015

ΑυξημÎνη χοληστερÏŒλη

Î‘Î½Î´ÏÎµÏ‚, 2008

ΑυξημÎνη γλυκÏŒζη αÎ¯ματος νηστε

Î‘Î½Î´ÏÎµÏ‚, 2014